Studies have shown that starting a high-efficacy DMT like Tysabri earlier in the disease course can also lead to less ...

Natalizumab is used to treat multiple sclerosis-MS. Tell your doctor right away if you have any side effects while this drug is being given or shortly after your treatment is finished. Examples of ...

A London hospital is to investigate why over half of its patients with multiple sclerosis (MS) who switched from disease modifying therapy Tysabri (natalizumab) to biosimilar Tyruko have had to be ...

natalizumab and Tyruko (natalizumab biosimilar) (after disease modifying therapy) [ID6369] Technology appraisal guidance 16 July 2025 Navitoclax with ruxolitinib for treating myelofibrosis when stem ...